Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOR/3TC/TDF vs BIC/FTC/TAF in ART-naïve HIV Patients With Overweight or Obesity
NCT07075146Phase 3Recruiting
- Start
- May 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doravirine, lamivudine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV). Started May 2025; status: recruiting.
02
Drugs
doravirinelamivudinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07075146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07075146.